Metropolis Healthcare has approved the grant of stock benefits to its eligible employees. This includes 18,232 units under the Restrictive Stock Unit Plan 2020, 10,107 units under the Restrictive Stock Units Plan 2025, and 228,840 options under the Employees Stock Options Plan 2025. The decision was made during a board meeting held on November 4, 2025.
Stock Benefit Approval
Metropolis Healthcare has officially announced the grant of stock benefits to its eligible employees. The approval was given by the Nomination and Remuneration Committee of the Board of Directors at a meeting held on November 4, 2025.
Details of Stock Benefits
The stock benefits granted include:
- 18,232 units under the Metropolis – Restrictive Stock Unit Plan, 2020.
- 10,107 units under the Metropolis – Restrictive Stock Units Plan, 2025.
- 228,840 options under the Metropolis – Employees Stock Options Plan, 2025.
Option Details
The pricing formula is the face value of shares, which is INR 2/- per unit, and INR 1,648.24/- per option. The minimum vesting period for all grants is 1 (one) year, and it may extend up to four years. The options can be exercised within a maximum period of 5 (five) years from the vesting date.
Source: BSE
